Computed tomography parameters as predictors of shock wave lithotripsy outcome
Urolithiasis · 2015 · Vol. 43 · Issue 1 · 69-75
Academy Summary
Computed tomography parameters as predictors of shock wave lithotripsy outcome examined a clinically important component of shock wave lithotripsy, with particular relevance to SWL Patient Selection & Outcome Prediction.
The evidence comes from a Retrospective Predictor Study involving patients undergoing swl for renal or ureteral stones. It reflects clinically relevant experience, but treatment selection and other unmeasured factors may have influenced the observed outcome.
CT attenuation and stone location were important outcome predictors, with an approximate 815-HU threshold proposed in the studied cohort
Such thresholds should be treated as probability markers rather than absolute rules.
Prediction tools estimate probability. They do not decide whether SWL is possible.
These studies are valuable because they move SWL selection from intuition toward quantifiable pre-treatment risk assessment, but they cannot measure the quality of the treatment actually delivered. Pre-treatment factors such as stone size, attenuation, skin-to-stone distance and location should be integrated rather than converted into isolated exclusion thresholds.
Published in 2015, the study should still be interpreted according to its specific lithotripter, patient selection and outcome definitions rather than assumed to represent every modern SWL system.
For the Lithotripsy Academy database, the paper is most useful when interpreted as part of the complete treatment pathway rather than as an isolated numerical rule. Patient selection determines the opportunity for success, while targeting, coupling, shock-wave rate, energy strategy and operator technique determine how effectively that opportunity is converted into fragmentation and clearance.
Comments & Discussion0 comments
Discuss the publication's evidence, limitations and practical relevance. Please do not include identifiable patient information or individual medical advice.
No comments yet. Start the discussion.
Please log in to join the discussion.
